It does sound like the Bioscrypt software may have been using, or at least could potentially use, the TPM, in which case the Bio-key CEO was mistaken. But as I re-read DePasquale’s statement, I see he was also implying that biometrics companies will have to address the TPM soon if they are not already doing it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.